Key Insights

Highlights

Success Rate

84% trial completion

Published Results

11 trials with published results (11%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

4.9%

5 terminated out of 103 trials

Success Rate

84.4%

-2.2% vs benchmark

Late-Stage Pipeline

3%

3 trials in Phase 3/4

Results Transparency

41%

11 of 27 completed with results

Key Signals

11 with results84% success

Data Visualizations

Phase Distribution

90Total
Not Applicable (49)
Early P 1 (2)
P 1 (9)
P 2 (27)
P 3 (1)
P 4 (2)

Trial Status

Recruiting37
Completed27
Not Yet Recruiting21
Unknown6
Terminated5
Active Not Recruiting5

Trial Success Rate

84.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (103)

Showing 20 of 20 trials
NCT06987513Phase 2CompletedPrimary

RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

NCT07735585Not ApplicableRecruitingPrimary

TRIS: Contingency Management App for Alcohol Use Disorder

NCT07734701Phase 2Not Yet RecruitingPrimary

Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder

NCT07559500Phase 1RecruitingPrimary

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

NCT02233868Early Phase 1CompletedPrimary

Brain Inflammation and Function in Alcoholism

NCT06629493Not ApplicableCompleted

Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder

NCT07451574Not ApplicableEnrolling By InvitationPrimary

Acceptability and Feasibility Study of Non-alcoholic Beverages

NCT07706660Not ApplicableNot Yet RecruitingPrimary

Body-Focused Mindfulness as an Add-on Intervention in Inpatient Alcohol Use Disorder Treatment (MBI-AUD-PL)

NCT07148843Phase 2Not Yet RecruitingPrimary

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

NCT07690423Not ApplicableNot Yet Recruiting

Prevention of Relapse Through Cognitive Cycling in Patients With Alcohol Use Disorder Following Alcohol Withdrawal

NCT06624137Terminated

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

NCT06727331Phase 2RecruitingPrimary

Study of Tirzepatide for Recovery and Alcohol Use Management

NCT05181891Phase 2RecruitingPrimary

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

NCT05134857Phase 2Active Not RecruitingPrimary

The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

NCT07573540Not ApplicableRecruiting

Optimizing Smart Technology for Addiction Recovery

NCT06679062Phase 2RecruitingPrimary

Suvorexant for Treatment of AUD and PTSD

NCT07279363Not ApplicableNot Yet Recruiting

Deaf CBT-TS to Reduce Suicide Risk

NCT06484075Phase 1Recruiting

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

NCT07503782Phase 2Not Yet RecruitingPrimary

OEA for Young Adults With Alcohol Use Disorder

NCT07488819Recruiting

Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974

Scroll to load more

Research Network

Activity Timeline